Ellipses In-Licenses First-in-Class B7H3 Antibody Drug Conjugate From China
The agreement grants Ellipses exclusive development rights to a novel antibody drug conjugate, potentially enhancing its oncology portfolio and creati...
Read Full Article →Create a free account to set price alerts and get notified when rates hit your targets.
Sign In with GoogleIt's free and takes seconds
The agreement grants Ellipses exclusive development rights to a novel antibody drug conjugate, potentially enhancing its oncology portfolio and creati...
Read Full Article →Pharmaceutical companies are advancing the development of specialized cancer treatments, potentially reducing reliance on chemotherapy and driving sig...
Read Full Article →Manage your PRO subscription and extension settings.
By signing in, you agree to our Terms and Privacy Policy
Free accounts can set 3 custom rates per week. Upgrade to Pro for unlimited custom rates.
Web Pro includes
Free accounts have 5 lifetime exports. Upgrade to Pro for unlimited exports.
Web Pro includes
Free accounts can lookup 5 historical dates. Upgrade to Pro for unlimited historical rates.
Web Pro includes
Historical charts beyond 1 year are available with Web Pro subscription.
Web Pro includes
Export directly to your cloud storage with Web Pro subscription.
Web Pro includes
=